Mazzone, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 3.537
AS - Asia 2.958
SA - Sud America 531
EU - Europa 430
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 54
OC - Oceania 3
Totale 7.671
Nazione #
US - Stati Uniti d'America 3.399
SG - Singapore 1.795
CN - Cina 509
BR - Brasile 443
VN - Vietnam 269
IT - Italia 156
HK - Hong Kong 131
CA - Canada 69
GB - Regno Unito 66
BD - Bangladesh 41
DE - Germania 37
IN - India 37
MX - Messico 33
ES - Italia 31
FR - Francia 25
AR - Argentina 23
IQ - Iraq 23
JP - Giappone 22
EC - Ecuador 21
TR - Turchia 20
ZA - Sudafrica 19
PL - Polonia 17
RU - Federazione Russa 16
PK - Pakistan 15
ID - Indonesia 14
NL - Olanda 13
UA - Ucraina 13
UZ - Uzbekistan 13
PY - Paraguay 11
AT - Austria 10
CO - Colombia 8
IE - Irlanda 8
KE - Kenya 8
VE - Venezuela 8
SE - Svezia 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 6
PH - Filippine 6
UY - Uruguay 6
JM - Giamaica 5
MY - Malesia 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
CR - Costa Rica 4
HN - Honduras 4
IL - Israele 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
BB - Barbados 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
FI - Finlandia 3
MN - Mongolia 3
AU - Australia 2
BE - Belgio 2
BG - Bulgaria 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
MZ - Mozambico 1
Totale 7.508
Città #
Singapore 740
San Jose 621
Ashburn 433
The Dalles 313
Dallas 183
Beijing 178
Shanghai 173
Council Bluffs 163
Hong Kong 125
Santa Clara 114
Ho Chi Minh City 99
Los Angeles 65
Hanoi 63
New York 56
Milan 54
São Paulo 38
Seattle 34
Boardman 30
Chicago 29
Montreal 25
Philadelphia 22
Phoenix 22
Assago 20
Buffalo 20
Denver 20
Rome 19
Atlanta 18
Chandler 18
Brooklyn 17
Da Nang 17
Princeton 17
Warsaw 17
Houston 16
Rio de Janeiro 16
Mexico City 15
Orem 15
Tokyo 15
Wilmington 15
Belo Horizonte 13
Boston 13
Abbeville 12
Miami 12
Tashkent 12
Amsterdam 10
Curitiba 10
Hải Dương 10
Johannesburg 10
London 10
Murcia 10
Charlotte 9
Haiphong 9
Manchester 9
Brasília 8
Chennai 8
Porto Alegre 8
Abbiategrasso 7
Ankara 7
Dhaka 7
Dublin 7
Figino 7
Munich 7
Naples 7
San Francisco 7
San Mateo 7
São José dos Campos 7
Amman 6
Baghdad 6
Basra 6
Cape Town 6
Guayaquil 6
Istanbul 6
Montevideo 6
Nairobi 6
Paris 6
Stockholm 6
Vienna 6
Arapiraca 5
Biên Hòa 5
Columbus 5
Jacksonville 5
Joinville 5
Lahore 5
Lancaster 5
Las Vegas 5
Lima 5
Milwaukee 5
Mumbai 5
Nashville 5
North Bergen 5
Queens 5
Quito 5
Reston 5
Turin 5
Asunción 4
Belém 4
Birmingham 4
Bến Tre 4
Cairo 4
Cleveland 4
Cuenca 4
Totale 4.277
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 171
Monocyte biomarkers for cancer detection 117
PHD2 inhibition for blood vessel normalization, and uses thereof 105
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 97
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 90
"Active" cancer immunotherapy by anti-Met antibody gene transfer 88
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates 78
Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation 75
B55α/PP2A limits endothelial cell apoptosis during vascular remodeling: A complementary approach to disrupt pathological vessels? 74
Modulating transendothelial migration and recruitment of granulocytes by modulating c-Met pathway 73
BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis 73
Tumor-associated macrophages: a short compendium 73
Building in resistance to endothelial cell death 68
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming 67
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels 66
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 66
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer 65
Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia 65
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis 65
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury 64
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling 64
Blood Vessel Proximity Shapes Cancer Cell Metabolism 63
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2 63
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis 62
Overcoming Resistance to Antiangiogenic Therapies 62
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer 62
The PP2A B55a subunit as novel PHD2 interacting protein and implications for cancer 62
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity 62
The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells 61
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization 59
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia 59
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis 58
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth 58
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? 58
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 58
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 58
Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness 57
Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way 57
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 57
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 57
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis 56
Induction/monitoring of arteriogenesis using SDF1 and PDGFB or inhibition of PHD2 56
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization 56
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 56
The Met pathway: master switch and drug target in cancer progression 55
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene 55
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 55
Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis 55
Genetic targeting of the kinase activity of the Met receptor in cancer cells 54
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited 54
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D 54
A collaborative synthetase 54
Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation 54
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 54
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival 54
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo 53
Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting 53
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma 53
Growing tumor vessels: More than one way to skin a cat - Implications for angiogenesis targeted cancer therapies 53
Neutrophils enhance early Trypanosoma brucei infection onset 53
Metabolic traits ruling the specificity of the immune response in different cancer types 53
FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? 51
PHD1 regulates p53-mediated colorectal cancer chemoresistance 51
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population 51
Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism 51
Tumour hypoxia causes DNA hypermethylation by reducing TET activity 50
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties 50
Caspase-8 modulates physiological and pathological angiogenesis during retina development 50
Macrophage-derived glutamine boosts satellite cells and muscle regeneration 50
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability 49
Leptin brain entry via a tanycytic LepR–EGFR shuttle controls lipid metabolism and pancreas function 49
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity 49
Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis 49
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis 49
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer 48
Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization 48
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism 48
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium 48
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF 47
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis 47
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 47
Immunity, hypoxia, and metabolism–the ménage à trois of cancer: Implications for immunotherapy 47
Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis 46
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 45
The impact of hypoxia on tumor-associated macrophages 45
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy 45
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 45
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 45
Metabolism and TAM functions—it takes two to tango 45
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 44
MET is required for the recruitment of anti-tumoural neutrophils 44
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner 44
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? 44
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site 44
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 44
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice 44
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity 44
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 43
Role of delta-like-4/notch in the formation and wiring of the lymphatic network in zebrafish 43
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation 43
Totale 5.803
Categoria #
all - tutte 44.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 3 0 0 0 2 0 2 6 5
2022/202345 5 2 3 7 2 4 0 5 11 3 3 0
2023/2024529 0 3 3 3 2 4 2 1 146 27 145 193
2024/20251.454 45 5 4 14 11 118 83 92 301 392 184 205
2025/20264.210 638 357 245 295 141 242 1.233 187 217 277 145 233
2026/20271.389 125 258 812 194 0 0 0 0 0 0 0 0
Totale 7.671